Lebwohl David (CIK 0001810882)

Latest company ownership

NTLA - Intellia Therapeutics, Inc.

Role: EVP, Chief Medical Officer

Shares held

61,714

Last filed at

Mar 4, 2025

Confidence Score

49.9

2025Q4

Confidence Score History

2021Q3 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Jan 3, 2025	Jan 7, 2025	Intellia Therapeutics, Inc.	EVP, Chief Medical Officer	Sell	42.5	-9,557	-9.83%	✗	$116.4K
Jan 3, 2024	Jan 5, 2024	Intellia Therapeutics, Inc.	EVP, Chief Medical Officer	Sell	42.5	-5,843	-9.70%	✗	$172.1K
Jan 4, 2023	Jan 6, 2023	Intellia Therapeutics, Inc.	EVP, Chief Medical Officer	Sell	42.5	-2,574	-9.11%	✗	$95.8K
Jan 1, 2022	Mar 3, 2022	Intellia Therapeutics, Inc.	EVP, Chief Medical Officer	Sell	95.0	+12,765	106.61%	✗	$118K
Nov 5, 2021	Nov 9, 2021	Intellia Therapeutics, Inc.	EVP, Chief Medical Officer	Sell	12.5	-2,400	-21.59%	✓	$318.5K
Oct 14, 2021	Oct 15, 2021	Intellia Therapeutics, Inc.	EVP, Chief Medical Officer	Sell	12.5	-2,400	-21.59%	✓	$308.2K
Sep 21, 2021	Sep 23, 2021	Intellia Therapeutics, Inc.	EVP, Chief Medical Officer	Sell	7.5	-2,400	-75.21%	✓	$359.5K
Aug 30, 2021	Sep 1, 2021	Intellia Therapeutics, Inc.	EVP, Chief Medical Officer	Sell	7.5	-2,400	-75.21%	✓	$379.3K
Aug 9, 2021	Aug 11, 2021	Intellia Therapeutics, Inc.	EVP, Chief Medical Officer	Sell	7.5	-2,400	-75.21%	✓	$393.7K